SER Gregory Bailey buys $47K worth of shares
Aug 20, 2024, 9:32 PM
-25.24%
What does SER do
AgeX Therapeutics, Inc., based in Alameda, California, focuses on developing and commercializing innovative therapeutics for aging and degenerative diseases using telomerase-expressing stem cells. Its key candidates, AGEX-BAT1 and AGEX-VASC1, target metabolic disorders and vascular diseases, respectively.
Gregory Bailey bought 6,400 shares of SER on 16 August at $7.31 per share, worth a total of $47K. They now own 39,406 SER shares, or a 19% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.